Jaime Merchan
@JaimeMerchan10
Followers
235
Following
367
Statuses
317
Oncologist, Physician Scientist, husband and proud father of 3!
Joined September 2017
RT @stuartpstevens: This amounts to the most significant data leak in cyber history. Private individuals in the data business now have acce…
0
7K
0
1
0
2
RT @dsui_miami_uro: Collaboration is key! Hear from top experts across disciplines as they tackle renal cell carcinoma treatment strategies…
0
6
0
@dsui_miami_uro @dipenjparekh @PKanaburMD @Dr_JihadKaouk @Jose_A_Karam @gonzomdphd @UclaUrology @bcm_urology @ClevelandClinic @MDAndersonNews We had a great discussion on the surgical and medical oncology management of challenging RCC cases! @UCLA, @ClevelandClinic, @MDAndersonNews and @SylvesterCancer in one table!
0
1
8
RT @DrChoueiri: 5/ And now @neerajaiims with a practice-informing trial for #Belzutifan in #RCC. More is not always better! The efficacy of…
0
20
0
RT @DrChoueiri: CLEAR study biomarker analysis with @motzermd and friends is out in @Annals_Oncology —thank you EIC @tompowles1 for a flawl…
0
26
0
RT @montypal: The finding of no predictive biomarker underscores that there is more work to be done! Hats off to @DrChoueiri @motzermd @CPR…
0
9
0
Today was our Phase 1 holiday celebration! Proud to be part of this incredible, hard working team, bringing new treatments, and hope for our patients in South Florida and beyond! Thank you team! Happy holidays!
0
1
7
@Latinamd @SylvesterCancer Thanks @Latinamd for sharing a great time woth the great Phase 1 team @SylvesterCancer! Best team! Ths sky is the limit!
0
0
1
Dr Antonio Iavarone, Deputy Director @SylvesterCancer discussing novel precision medicine approaches for high grade gliomas at the 2nd annual TCO Symposium!
0
1
2
Dr Damian Green, chief, Div Of Transplantation and Cellular Therapy @SylvesterCancer discussing mechanisms of immunotx resistance and strategies to overcome them, and bench to bedside strategies led by him and his group! @DrOlaLandgren
0
1
3
Dr Marc Theoret from @US_FDA discussing initiatives to enhance development of novel endpoints in oncology drug development, including immunotherapies! @SylvesterCancer 2nd TCO Symposium, Miami, Florida
0
0
3
RT @jasonlukemd: Enjoying amazing science & discussion at translational cancer #immunotherapy symposium @SylvesterCancer Beautiful campus,…
0
7
0
@jasonlukemd @SylvesterCancer @umiamimedicine @sitcancer @UPMCHillmanCC @PittDeptofMed @UMiamiHealth @DrOlaLandgren @LutzkyJose @DemariaLab_WCM @LabSignoretti @MarcelaMaus @PeterHoseinMD Learning from world leaders at the second TCO annual symposium!
0
0
3
@jasonlukemd @SylvesterCancer @umiamimedicine @sitcancer @UPMCHillmanCC @PittDeptofMed @UMiamiHealth @DrOlaLandgren @LutzkyJose @DemariaLab_WCM @LabSignoretti @MarcelaMaus @PeterHoseinMD Thanks @jasonlukemd, for sharing your innovative science! We had an incredible morning, with yours and other inspiring talks by Dr Cathy Wu (Dana Farber), @DemariaLab_WCM, @PeterHoseinMD @JuanAlderuccio! And Sabina Signoretti (@BrighamWomens )!
0
0
1
@CarlosArteagaMD @theNAMedicine @VanderbiltU @UTSWMedCenter Congratulations @CarlosArteagaMD! Well deserved!
0
0
1
@Latinamd @SylvesterCancer @CarmenCalfa @jessiemac07 @DrFrankJPenedo Thanks @Latinamd! As a phase 1 investigator, you will play a critical role in our new Phase 1 initiative! @SylvesterCancer
0
0
1
@COlazagasti @montypal @SylvesterCancer @NazliDizman @ReginaBarCar @GlopesMd @Florez_Lab @Latinamd You are right @COlazagasti! Honored to have @montypal, one of the most influential RCC docs and translational researchers share his impactful research at our @SylvesterCancer Translational and Clinical Oncology (TCO) seminar!@DrOlaLandgren @GlopesMd @mbilusic @NimaSharifiMD
0
3
6
Today we visited the new Kenneth C. Griffin Cancer Research Building, future home of our @SylvesterCancer Phase 1 Unit! Here we will continue bringing new treatments and hope for our cancer patients! Go Sylvester!
0
0
9